Glucotrack Inc (GCTK)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -22,597 | -12,503 | -7,416 | -2,927 | -7,097 |
| Depreciation Amortization | 36 | 352 | 12 | 4 | 13 |
| Accounts payable and accrued liabilities | 263 | 1,129 | 1,897 | 175 | 167 |
| Other Working Capital | 67 | 1,235 | 2,204 | -118 | 190 |
| Other Operating Activity | 9,741 | 796 | -1,546 | -76 | 169 |
| Operating Cash Flow | $-12,490 | $-8,991 | $-4,849 | $-2,942 | $-6,558 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -104 | -104 | -71 | -59 | N/A |
| Investing Cash Flow | $-104 | $-104 | $-71 | $-59 | $N/A |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 4,460 | 4,460 | 80 | N/A | N/A |
| Other Financing Activity | 9,283 | 500 | 500 | 0 | 8,730 |
| Financing Cash Flow | $13,743 | $4,960 | $580 | $N/A | $8,730 |
| Exchange Rate Effect | -24 | -11 | 6 | 6 | -1 |
| Beginning Cash Position | 4,502 | 4,502 | 4,502 | 4,502 | 2,331 |
| End Cash Position | 5,627 | 356 | 168 | 1,507 | 4,502 |
| Net Cash Flow | $1,125 | $-4,146 | $-4,334 | $-2,995 | $2,171 |
| Free Cash Flow | |||||
| Operating Cash Flow | -12,490 | -8,991 | -4,849 | -2,942 | -6,558 |
| Capital Expenditure | -104 | -104 | -71 | -59 | N/A |
| Free Cash Flow | -12,594 | -9,095 | -4,920 | -3,001 | -6,558 |